Risk Factors and Costs Associated With 1‐Year Mortality and Readmission After Leadless Pacemaker Implantation
The large healthcare expenditure derives from high rates of readmission and in-hospital mortality, with readmissions potentially representing a modifiable target. CHF is a prominent cause of poor outcomes, which suggests the need to consider the overlapping roles of conduction system pacing, goal-directed medical therapy, and close clinical follow-up.
Authors
- Peter Zimetbaum (ORCID: https://orcid.org/0000-0002-7958-7558)
- Peter G. Brodeur (ORCID: https://orcid.org/0000-0002-7391-719X)
- Daniel B. Kramer (ORCID: https://orcid.org/0000-0003-4241-3586)
- Andrew H. Locke (ORCID: https://orcid.org/0000-0002-2766-4726)
- Toby M. Maher (ORCID: https://orcid.org/0000-0001-7192-9149)
- Jonathan W. Waks (ORCID: https://orcid.org/0000-0001-5560-5638)
- Amanda Avila
- Robert W. Yeh (ORCID: https://orcid.org/0000-0002-0564-4468)
- Shu Yang (ORCID: https://orcid.org/0000-0001-7736-6703)
- Gregory F. Michaud (ORCID: https://orcid.org/0009-0006-8425-4455)
- Enrico G. Ferro (ORCID: https://orcid.org/0000-0001-9190-6331)
- ZhaoNian Zheng
- Patricia Tung
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Deaconess Hospital (US)
Publication Details
- Journal
- Pacing and Clinical Electrophysiology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1111/pace.15207
- Primary Topic
- Cardiac pacing and defibrillation studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00